A Temporary Extension for the Rare Pediatric Disease Priority Review Voucher with a Longer-Term Extension in Sight?
FDA Law Blog
OCTOBER 13, 2024
While the dates have been written in the law, the previous extensions provided a reasonable hope that the program would continue. It was shortly thereafter introduced in the Senate and referred to the Committee on Health Education, Labor, and Pensions, where it remains. After all, this is what incentives are for.
64 
Let's personalize your content